Renin Substrate Tetradecapeptide human

(3S,4E,6S,7E,9S,10E,12S,13E,15S,16S)-3-Amino-15-[(E)-{[(2S)-1-{(2S)-2-[(1E,3S,4Z,6S,7Z,9S,10Z,12S,13Z,15S,16Z,18S,19Z,21S)-3-benzyl-15-[(2S)-2-butanyl]-21-carboxy-1,4,7,10,13,16,19,23-octahydroxy-6,18 -bis(1H-imidazol-5-ylmethyl)-23-imino-9-isobutyl-12-isopropyl-2,5,8,11,14,17,20-heptaazatricosa-1,4,7,10,13,16,19-heptaen-1-yl]-1-pyrrolidinyl}-3-(1H-imidazol-5-yl)-1-oxo-2-propanyl]imino}(hydroxy)met hyl]-6-(3-carbamimidamidopropyl)-4,7,10,13-tetrahydroxy-12-(4-hydroxybenzyl)-9-isopropyl-16-methyl-5,8,11,14-tetraazaoctadeca-4,7,10,13-tetraen-1-oic acid

104180-23-6

3,6,9,12,15-Pentaazanonadeca-3,6,9,12,15-pentaen-19-oic acid, 17-amino-14-[3-[(aminoiminomethyl)amino]propyl]-1-[(2S)-2-[(1E,3S,4Z,6S,7Z,9S,10Z,12S,13Z,15S,16Z,18S,19Z,21S)-21-carboxy-1,4,7,10,13,16,1 9,23-octahydroxy-6,18-bis(1H-imidazol-5-ylmethyl)-23-imino-12-(1-methylethyl)-15-[(1S)-1-methylpropyl]-9-(2-methylpropyl)-3-(phenylmethyl)-2,5,8,11,14,17,20-heptaazatricosa-1,4,7,10,13,16,19-heptaen-1 -yl]-1-pyrrolidinyl]-4,7,10,13,16-pentahydro

L-α-Asparagyl-L-arginyl-L-valyltyrosyl-L-isoleucylhistidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucyl-L-valyl-L-isoleucyl-L-histidyl-L-asparagin

L-α-Aspartyl-L-arginyl-L-valyltyrosyl-L-isoleucylhistidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucyl-L-valyl-L-isoleucyl-L-histidyl-L-asparagine

L-α-Aspartyl-L-arginyl-L-valyltyrosyl-L-isoleucylhistidyl-L-prolyl-L-phénylalanyl-L-histidyl-L-leucyl-L-valyl-L-isoleucyl-L-histidyl-L-asparagine

Renin Substrate Tetradecapeptide human

Angiotensinogen

Angiotensinogen (1-14), Human

H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn-OH

L-Asparagine, L-a-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucyl-L-valyl-L-isoleucyl-L-histidyl-